ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study

Xiang, Meijuan; Liang, Zongyu; Gao, Yuan; Feng, Xingyu*; Yao, Xueqing*广东省人民医院; 南方医科大学; 6; 5
Frontiers in Surgery2022-10-26DOI: 10.3389/fsurg.2022.1022025
1被引3閱讀
引用收藏
分享

摘要

BackgroundNeoadjuvant chemotherapy (NAC) could improve local tumor control of locally advanced colon cancer (LACC), but the prognostic value of yp stage in colon cancer remains unknown. Here, we aimed to ascertain yp stage as an indicator for LACC prognosis after NAC. MethodsThe data of patients diagnosed with colon adenocarcinoma between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and End Results database. After 1:2 propensity score matching, cancer-specific survival (CSS) and overall survival (OS) were compared between the NAC and Non-NAC groups of different stage classifications. The correlation between clinical and pathological factors and CSS was identified. ResultsA total of 49, 149, and 81 matched pairs of stage 0-I, II, and III patients, respectively, were generated for analysis. For stage 0-I (p = 0.011) and III (p = 0.015), only CSS in the NAC groups were inferior. Receiving NAC was an independent prognostic risk factor for patients with stage 0-I (hazard ratio, 7.70; 95% confidence interval, 1.820-32.5; p = 0.006) and stage III (hazard ratio, 1.73; 95% confidence interval, 1.11-2.68; p = 0.015). ConclusionsThe CSS was poorer among LACC patients who underwent NAC than among those who did not. The yp stage of colon cancer after NAC has distinctive significance, which may contribute to predicting the prognosis and guiding the treatment of LACC patients after NAC.

學科與關鍵詞

關鍵詞
prognostic valueneoadjuvant chemotherapycolon canceryp stagesurvival
相關
載入中…
  • Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study
    Lv, Zhihao*; Liang, Yuqi; Liu, Huaxi; Mo, DelongBMC CANCER, 2021, 21(1): 306.被引 10
  • The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis
    Liang, Zongyu*; Li, Zhu; Yang, Qingshui; Feng, Jiahao; Xiang, Deyu; Lyu, Haina; Mai, Guangzhi; Wang, Wanchuan*Frontiers in Oncology, 2022, 12: 1024345.被引 1
  • Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis
    Zhou, Huabin; Wang, Songsheng; Cai, Zhai; Qiu, Enming; Chen, Qianyun; Rao, Xi; Han, Shuai; Li, Zhou*INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37(12): 2481-2489.
查看全部 →

發表資訊

論文狀態
公開發表
期刊
Frontiers in Surgery
發表日期
2022-10-26
卷期
第 9 卷
頁碼
1022025
DOI
10.3389/fsurg.2022.1022025
期刊等級
3区
成果收錄
SCIE

作者

  • X

    Xiang, Meijuan (第一作者)

    guangdong prov peoples hosp

  • L

    Liang, Zongyu

    2 · 6

查看全部 5 位作者收起作者
  • G

    Gao, Yuan

    2 · southern med univ

  • F

    Feng, Xingyu (通訊)

    guangdong prov peoples hosp

  • Y

    Yao, Xueqing (通訊)

    5 · gannan med univ · guangdong prov peoples hosp · 2 · southern med univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417